Table 1.
Baseline characteristics of patients.
| Anastrozole n (%) | Fulvestrant n (%) | |
|---|---|---|
| Age | ||
| ≤70 years | 59 (53.2) | 46 (43.4) |
| >70 years | 52 (46.8) | 60 (56.6) |
| T | ||
| T2 | 87 (78.4) | 73 (68.9) |
| T3 | 13 (11.7) | 18 (17.0) |
| T4 | 11 (9.9) | 15 (14.1) |
| N | ||
| N0 | 77 (69.4) | 67 (63.2) |
| N1 | 34 (30.6) | 39 (36.8) |
| Histological type | ||
| Ductal | 73 (65.8) | 63 (59.4) |
| Lobular | 34 (30.6) | 38 (35.9) |
| Other | 4 (3.6) | 5 (4.7) |
| Histological grade | ||
| Grade 1 | 21 (18.9) | 21 (19.8) |
| Grade 2 | 82 (73.9) | 73 (68.9) |
| Grade 3 | 5 (4.5) | 10 (9.4) |
| NA | 3 (2.7) | 2 (1.9) |
| Baseline ER Allred score | ||
| 4–5 | 1 (0.9) | 2 (1.9) |
| 6–8 | 110 (99.1) | 104 (98.1) |
| Baseline Ki-67 | ||
| ≤10% | 38 (34.2) | 34 (32.1) |
| >10% | 56 (50.5) | 52 (49.0) |
| NA | 17 (15.3) | 20 (18.9) |
NA not available.